{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:05:32Z","timestamp":1760123132746,"version":"3.37.3"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T00:00:00Z","timestamp":1633824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T00:00:00Z","timestamp":1633824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Young children with sickle cell anaemia (SCA) often have slowed processing speed associated with reduced brain white matter integrity, low oxygen saturation, and sleep-disordered breathing (SDB), related in part to enlarged adenoids and tonsils. Common treatments for SDB include adenotonsillectomy and nocturnal continuous positive airway pressure (CPAP), but adenotonsillectomy is an invasive surgical procedure, and CPAP is rarely well-tolerated. Further, there is no current consensus on the ability of these treatments to improve cognitive function. Several double-blind, randomised controlled trials (RCTs) have demonstrated the efficacy of montelukast, a safe, well-tolerated anti-inflammatory agent, as a treatment for airway obstruction and reducing adenoid size for children who do not have SCA. However, we do not yet know whether montelukast reduces adenoid size and improves cognition function in young children with SCA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The Study of Montelukast In Children with Sickle Cell Disease (SMILES) is a 12-week multicentre, double-blind, RCT. SMILES aims to recruit 200 paediatric patients with SCA and SDB aged 3\u20137.99\u2009years to assess the extent to which montelukast can improve cognitive function (i.e. processing speed) and sleep and reduce adenoidal size and white matter damage compared to placebo. Patients will be randomised to either montelukast or placebo for 12\u2009weeks. The primary objective of the SMILES trial is to assess the effect of montelukast on processing speed in young children with SCA. At baseline and post-treatment, we will administer a cognitive evaluation; caregivers will complete questionnaires (e.g. sleep, pain) and measures of demographics. Laboratory values will be obtained from medical records collected as part of standard care. If a family agrees, patients will undergo brain MRIs for adenoid size and other structural and haemodynamic quantitative measures at baseline and post-treatment, and we will obtain overnight oximetry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Findings from this study will increase our understanding of whether montelukast is an effective treatment for young children with SCA. Using cognitive testing and MRI, the SMILES trial hopes to gain critical knowledge to help develop targeted interventions to improve the outcomes of young children with SCA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>NCT04351698. Registered on April 17, 2020. European Clinical Trials Database (EudraCT No. 2017-004539-36). Registered on May 19, 2020<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13063-021-05626-6","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T21:51:02Z","timestamp":1633902662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Study of montelukast in children with sickle cell disease (SMILES): a study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"22","author":[{"given":"Anna M.","family":"Hood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Stotesbury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"K\u00f6lbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"DeHaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Downes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie M.","family":"Kawadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satwinder","family":"Sahota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmara","family":"Dimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baba","family":"Inusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olu","family":"Wilkey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Pelidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Trompeter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Leigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Younis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Drasar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subarna","family":"Chakravorty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Rees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Height","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Gavlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Ridout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2443-7958","authenticated-orcid":false,"given":"Fenella J.","family":"Kirkham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,10]]},"reference":[{"issue":"9757","key":"5626_CR1","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018\u201331. https:\/\/doi.org\/10.1016\/S0140-6736(10)61029-X.","journal-title":"Lancet"},{"issue":"12","key":"5626_CR2","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1182\/blood.V81.12.3422.3422","volume":"81","author":"WR Rackoff","year":"1993","unstructured":"Rackoff WR, Kunkel N, Silber JH, Asakura T, Ohene-Frempong K. Pulse oximetry and factors associated with hemoglobin oxygen desaturation in children with sickle cell disease. Blood. 1993;81(12):3422\u20137. https:\/\/doi.org\/10.1182\/blood.V81.12.3422.3422.","journal-title":"Blood"},{"issue":"6","key":"5626_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2471\/blt.06.036673","volume":"86","author":"B Modell","year":"2008","unstructured":"Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480\u20137. https:\/\/doi.org\/10.2471\/blt.06.036673.","journal-title":"Bull World Health Organ"},{"issue":"23","key":"5626_CR4","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","volume":"330","author":"OS Platt","year":"1994","unstructured":"Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease--life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639\u201344. https:\/\/doi.org\/10.1056\/NEJM199406093302303.","journal-title":"N Engl J Med"},{"issue":"7","key":"5626_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001484","volume":"10","author":"FB Piel","year":"2013","unstructured":"Piel FB, Hay SI, Gupta S, Weatherall DJ, Williams TN. Global burden of sickle cell anaemia in children under five, 2010\u20132050: modelling based on demographics, excess mortality, and interventions. PLoS Med. 2013;10(7):e1001484. https:\/\/doi.org\/10.1371\/journal.pmed.1001484.","journal-title":"PLoS Med"},{"issue":"7","key":"5626_CR6","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3324\/haematol.10937","volume":"92","author":"P Telfer","year":"2007","unstructured":"Telfer P, Coen P, Chakravorty S, Wilkey O, Evans J, Newell H, et al. Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London. Haematologica. 2007;92(7):905\u201312. https:\/\/doi.org\/10.3324\/haematol.10937.","journal-title":"Haematologica"},{"issue":"7","key":"5626_CR7","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1182\/blood-2015-09-618579","volume":"127","author":"MR DeBaun","year":"2016","unstructured":"DeBaun MR, Kirkham FJ. Central nervous system complications and management in sickle cell disease: a review. Blood. 2016;127(7):829\u201338. https:\/\/doi.org\/10.1182\/blood-2015-09-618579.","journal-title":"Blood"},{"issue":"20","key":"5626_CR8","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1182\/blood-2011-02-272682","volume":"119","author":"MR DeBaun","year":"2012","unstructured":"DeBaun MR, Armstrong FD, McKinstry RC, et al. Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood. 2012;119(20):4587\u201396. https:\/\/doi.org\/10.1182\/blood-2011-02-272682.","journal-title":"Blood"},{"issue":"1","key":"5626_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/bjh.13525","volume":"171","author":"MI Cancio","year":"2015","unstructured":"Cancio MI, Helton KJ, Schreiber JE, Smeltzer MP, Kang G, Wang WC. Silent cerebral infarcts in very young children with sickle cell anaemia are associated with a higher risk of stroke. Br J Haematol. 2015;171(1):120\u20139. https:\/\/doi.org\/10.1111\/bjh.13525.","journal-title":"Br J Haematol"},{"issue":"7","key":"5626_CR10","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/dmcn.13113","volume":"58","author":"JM Kawadler","year":"2016","unstructured":"Kawadler JM, Clayden JD, Clark CA, Kirkham FJ. Intelligence quotient in paediatric sickle cell disease: a systematic review and meta-analysis. Dev Med Child Neurol. 2016;58(7):672\u20139. https:\/\/doi.org\/10.1111\/dmcn.13113.","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"5626_CR11","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1093\/jpepsy\/jsz031","volume":"44","author":"KV Prussien","year":"2019","unstructured":"Prussien KV, Jordan LC, DeBaun MR, et al. Cognitive function in sickle cell disease across domains, cerebral infarct status, and the lifespan: A Meta-Analysis. J Pediatr Psychol. 2019;44(8):948\u201358. https:\/\/doi.org\/10.1093\/jpepsy\/jsz031.","journal-title":"J Pediatr Psychol"},{"issue":"1","key":"5626_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1017\/S1355617711001469","volume":"18","author":"MJ Hollocks","year":"2012","unstructured":"Hollocks MJ, Kok TB, Kirkham FJ, Gavlak J, Inusa BP, DeBaun MR, et al. Nocturnal oxygen desaturation and disordered sleep as a potential factor in executive dysfunction in sickle cell anemia. J Int Neuropsychol Soc. 2012;18(1):168\u201373. https:\/\/doi.org\/10.1017\/S1355617711001469.","journal-title":"J Int Neuropsychol Soc"},{"issue":"2","key":"5626_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/jpepsy\/26.2.69","volume":"26","author":"RB Noll","year":"2001","unstructured":"Noll RB, Stith L, Gartstein MA, Ris MD, Grueneich R, Vannatta K, et al. Neuropsychological functioning of youths with sickle cell disease: comparison with non-chronically ill peers. J Pediatr Psychol. 2001;26(2):69\u201378. https:\/\/doi.org\/10.1093\/jpepsy\/26.2.69.","journal-title":"J Pediatr Psychol"},{"issue":"2","key":"5626_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/088307380201700204","volume":"17","author":"RG Steen","year":"2002","unstructured":"Steen RG, Hu XJ, Elliott VE, et al. Kindergarten readiness skills in children with sickle cell disease: evidence of early neurocognitive damage? J Child Neurol. 2002;17(2):111\u20136. https:\/\/doi.org\/10.1177\/088307380201700204.","journal-title":"J Child Neurol"},{"issue":"2","key":"5626_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/09297040600611312","volume":"13","author":"RA Tarazi","year":"2007","unstructured":"Tarazi RA, Grant ML, Ely E, Barakat LP. Neuropsychological functioning in preschool-age children with sickle cell disease: the role of illness-related and psychosocial factors. Child Neuropsychol. 2007;13(2):155\u201372. https:\/\/doi.org\/10.1080\/09297040600611312.","journal-title":"Child Neuropsychol"},{"issue":"1","key":"5626_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/jpepsy\/28.1.59","volume":"28","author":"RJ Thompson","year":"2003","unstructured":"Thompson RJ, Armstrong FD, Link CL, et al. A prospective study of the relationship over time of behavior problems, intellectual functioning, and family functioning in children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr Psychol. 2003;28(1):59\u201365. https:\/\/doi.org\/10.1093\/jpepsy\/28.1.59.","journal-title":"J Pediatr Psychol"},{"issue":"10","key":"5626_CR17","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1177\/0883073812453495","volume":"28","author":"AM Hogan","year":"2013","unstructured":"Hogan AM, Telfer PT, Kirkham FJ, Haan M. Precursors of executive function in infants with sickle cell anemia. J Child Neurol. 2013;28(10):1197\u2013202. https:\/\/doi.org\/10.1177\/0883073812453495.","journal-title":"J Child Neurol"},{"issue":"8","key":"5626_CR18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/jpepsy\/27.8.739","volume":"27","author":"J Schatz","year":"2002","unstructured":"Schatz J, Finke RL, Kellett JM, Kramer JH. Cognitive functioning in children with sickle cell disease: a meta-analysis. J Pediatr Psychol. 2002;27(8):739\u201348. https:\/\/doi.org\/10.1093\/jpepsy\/27.8.739.","journal-title":"J Pediatr Psychol"},{"issue":"3","key":"5626_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1067\/mpd.2001.116935","volume":"139","author":"W Wang","year":"2001","unstructured":"Wang W, Enos L, Gallagher D, Thompson R, Guarini L, Vichinsky E, et al. Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001;139(3):391\u20137. https:\/\/doi.org\/10.1067\/mpd.2001.116935.","journal-title":"J Pediatr"},{"key":"5626_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27899","volume":"66","author":"AM Hood","year":"2019","unstructured":"Hood AM, King AA, Fields ME, Ford AL, Guilliams KP, Hulbert ML, et al. Higher executive abilities following a blood transfusion in children and young adults with sickle cell disease. Pediatr Blood Cancer. 2019;66:e27899. https:\/\/doi.org\/10.1002\/pbc.27899.","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"5626_CR21","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/pbc.26019","volume":"63","author":"SJ Hardy","year":"2016","unstructured":"Hardy SJ, Hardy KK, Schatz JC, Thompson AL, Meier ER. Feasibility of home-based computerized working memory training with children and adolescents with sickle cell disease. Pediatr Blood Cancer. 2016;63(9):1578\u201385. https:\/\/doi.org\/10.1002\/pbc.26019.","journal-title":"Pediatr Blood Cancer"},{"issue":"23","key":"5626_CR22","doi-asserted-by":"publisher","first-page":"E2042","DOI":"10.1212\/WNL.0000000000005644","volume":"90","author":"H Stotesbury","year":"2018","unstructured":"Stotesbury H, Kirkham FJ, K\u00f6lbel M, Balfour P, Clayden JD, Sahota S, et al. White matter integrity and processing speed in sickle cell anemia. Neurology. 2018;90(23):E2042\u201350. https:\/\/doi.org\/10.1212\/WNL.0000000000005644.","journal-title":"Neurology"},{"issue":"3","key":"5626_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/DBP.0b013e31824ba1b5","volume":"33","author":"B Daly","year":"2012","unstructured":"Daly B, Kral MC, Brown RT, Elkin D, Madan-Swain A, Mitchell M, et al. Ameliorating attention problems in children with sickle cell disease: a pilot study of methylphenidate. J Dev Behav Pediatr. 2012;33(3):244\u201351. https:\/\/doi.org\/10.1097\/DBP.0b013e31824ba1b5.","journal-title":"J Dev Behav Pediatr"},{"issue":"4","key":"5626_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10880-019-09654-y","volume":"27","author":"AM Hood","year":"2019","unstructured":"Hood AM, Reife I, King AA, White DA. Brief screening measures identify risk for psychological difficulties among children with sickle cell disease. J Clin Psychol Med Settings. 2019;27(4):1\u201311. https:\/\/doi.org\/10.1007\/s10880-019-09654-y.","journal-title":"J Clin Psychol Med Settings"},{"issue":"9269","key":"5626_CR25","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/S0140-6736(00)04821-2","volume":"357","author":"FJ Kirkham","year":"2001","unstructured":"Kirkham FJ, Hewes DKM, Prengler M, Wade A, Lane R, Evans JPM. Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease. Lancet. 2001;357(9269):1656\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(00)04821-2.","journal-title":"Lancet"},{"issue":"4","key":"5626_CR26","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1365-2141.2009.07660.x","volume":"145","author":"J Makani","year":"2009","unstructured":"Makani J, Kirkham FJ, Komba A, Ajala-Agbo T, Otieno G, Fegan G, et al. Risk factors for high cerebral blood flow velocity and death in Kenyan children with sickle cell anaemia: role of haemoglobin oxygen saturation and febrile illness. Br J Haematol. 2009;145(4):529\u201332. https:\/\/doi.org\/10.1111\/j.1365-2141.2009.07660.x.","journal-title":"Br J Haematol"},{"issue":"6","key":"5626_CR27","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/bjh.13916","volume":"172","author":"J Sommet","year":"2016","unstructured":"Sommet J, Alberti C, Couque N, Verlhac S, Haouari Z, Mohamed D, et al. Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective study. Br J Haematol. 2016;172(6):966\u201377. https:\/\/doi.org\/10.1111\/bjh.13916.","journal-title":"Br J Haematol"},{"issue":"7","key":"5626_CR28","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1161\/STROKEAHA.115.008721","volume":"46","author":"JM Kawadler","year":"2015","unstructured":"Kawadler JM, Kirkham FJ, Clayden JD, Hollocks MJ, Seymour EL, Edey R, et al. White matter damage relates to oxygen saturation in children with sickle cell anemia without silent cerebral infarcts. Stroke. 2015;46(7):1793\u20139. https:\/\/doi.org\/10.1161\/STROKEAHA.115.008721.","journal-title":"Stroke"},{"issue":"2","key":"5626_CR29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/ajh.23604","volume":"89","author":"AA King","year":"2014","unstructured":"King AA, Strouse JJ, Rodeghier MJ, Compas BE, Casella JF, McKinstry RC, et al. Parent education and biologic factors influence on cognition in sickle cell anemia. Am J Hematol. 2014;89(2):162\u20137. https:\/\/doi.org\/10.1002\/ajh.23604.","journal-title":"Am J Hematol"},{"issue":"4","key":"5626_CR30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1467-7687.2006.00503.x","volume":"9","author":"AM Hogan","year":"2006","unstructured":"Hogan AM, Pitten Cate IM, Vargha-Khadem F, et al. Physiological correlates of intellectual function in children with sickle cell disease: hypoxaemia, hyperaemia and brain infarction. Dev Sci. 2006;9(4):379\u201387. https:\/\/doi.org\/10.1111\/j.1467-7687.2006.00503.x.","journal-title":"Dev Sci"},{"issue":"7","key":"5626_CR31","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3324\/haematol.2008.005215","volume":"94","author":"MJ Marshall","year":"2009","unstructured":"Marshall MJ, Bucks RS, Hogan AM, Hambleton IR, Height SE, Dick MC, et al. Auto-adjusting positive airway pressure in children with sickle cell anemia: results of a phase I randomized controlled trial. Haematologica. 2009;94(7):1006\u201310. https:\/\/doi.org\/10.3324\/haematol.2008.005215.","journal-title":"Haematologica"},{"issue":"4","key":"5626_CR32","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/ppul.23932","volume":"53","author":"A De","year":"2018","unstructured":"De A, Manwani D, Rastogi D. Airway inflammation in sickle cell disease\u2014a translational perspective. Pediatric Pulmonology. 2018;53(4):400\u201311. https:\/\/doi.org\/10.1002\/ppul.23932.","journal-title":"Pediatric Pulmonology"},{"issue":"2","key":"5626_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1513\/pats.200707-111MG","volume":"5","author":"ES Katz","year":"2008","unstructured":"Katz ES, D\u2019Ambrosio CM. Pathophysiology of pediatric obstructive sleep apnea. Proc Am Thoracic Soc. 2008;5(2):253\u201362. https:\/\/doi.org\/10.1513\/pats.200707-111MG.","journal-title":"Proc Am Thoracic Soc"},{"issue":"3","key":"5626_CR34","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.anl.2014.12.005","volume":"42","author":"M Hamada","year":"2015","unstructured":"Hamada M, Iida M, Nota J, Matsumoto N, Sawada S, Mukushita N, et al. Safety and efficacy of adenotonsillectomy for obstructive sleep apnea in infants, toddlers and preschool children. Auris Nasus Larynx. 2015;42(3):208\u201312. https:\/\/doi.org\/10.1016\/j.anl.2014.12.005.","journal-title":"Auris Nasus Larynx"},{"issue":"25","key":"5626_CR35","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1056\/NEJMoa1215881","volume":"368","author":"CL Marcus","year":"2013","unstructured":"Marcus CL, Moore RH, Rosen CL, Giordani B, Garetz SL, Taylor HG, et al. A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med. 2013;368(25):2366\u201376. https:\/\/doi.org\/10.1056\/NEJMoa1215881.","journal-title":"N Engl J Med"},{"issue":"9","key":"5626_CR36","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1164\/rccm.201112-2167OC","volume":"185","author":"CL Marcus","year":"2012","unstructured":"Marcus CL, Radcliffe J, Konstantinopoulou S, Beck SE, Cornaglia MA, Traylor J, et al. Effects of positive airway pressure therapy on neurobehavioral outcomes in children with obstructive sleep apnea. Am J Respir Crit Care Med. 2012;185(9):998\u20131003. https:\/\/doi.org\/10.1164\/rccm.201112-2167OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"5626_CR37","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/194589240501900611","volume":"19","author":"EO Meltzer","year":"2005","unstructured":"Meltzer EO, Philip G, Weinstein SF, LaForce CF, Malice MP, Dass SB, et al. Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis. Am J Rhinol. 2005;19(6):591\u20138. https:\/\/doi.org\/10.1177\/194589240501900611.","journal-title":"Am J Rhinol"},{"key":"5626_CR38","doi-asserted-by":"publisher","unstructured":"Venekamp RP, Hearne BJ, Chandrasekharan D, Blackshaw H, Lim J, Schilder AGM, et al. Tonsillectomy or adenotonsillectomy versus non-surgical management for obstructive sleep-disordered breathing in children. Cochrane Database of Systematic Reviews. 2015:1465\u2013858. https:\/\/doi.org\/10.1002\/14651858.CD011165.pub2.","DOI":"10.1002\/14651858.CD011165.pub2"},{"issue":"1","key":"5626_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5665\/sleep.3312","volume":"37","author":"SN Biggs","year":"2014","unstructured":"Biggs SN, Vlahandonis A, Anderson V, Bourke R, Nixon GM, Davey MJ, et al. Long-term changes in neurocognition and behavior following treatment of sleep disordered breathing in school-aged children. Sleep. 2014;37(1):77\u201384. https:\/\/doi.org\/10.5665\/sleep.3312.","journal-title":"Sleep"},{"issue":"2","key":"5626_CR40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/ppul.21534","volume":"47","author":"YE Landau","year":"2012","unstructured":"Landau YE, Bar-Yishay O, Greenberg-Dotan S, Goldbart AD, Tarasiuk A, Tal A. Impaired behavioral and neurocognitive function in preschool children with obstructive sleep apnea. Pediatr Pulmonol. 2012;47(2):180\u20138. https:\/\/doi.org\/10.1002\/ppul.21534.","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"5626_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1542\/peds.2013-4223","volume":"134","author":"CL Rosen","year":"2014","unstructured":"Rosen CL, Debaun MR, Strunk RC, Redline S, Seicean S, Craven DI, et al. Obstructive sleep apnea and sickle cell anemia. Pediatrics. 2014;134(2):273\u201381. https:\/\/doi.org\/10.1542\/peds.2013-4223.","journal-title":"Pediatrics"},{"issue":"9","key":"5626_CR42","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/MPH.0b013e31817eb7ef","volume":"30","author":"J Kaleyias","year":"2008","unstructured":"Kaleyias J, Mostofi N, Grant M, Coleman C, Luck L, Dampier C, et al. Severity of obstructive sleep apnea in children with sickle cell disease. J Pediatr Hematol Oncol. 2008;30(9):659\u201365. https:\/\/doi.org\/10.1097\/MPH.0b013e31817eb7ef.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"5626_CR43","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/ppul.23074","volume":"50","author":"MI Mascarenhas","year":"2015","unstructured":"Mascarenhas MI, Loureiro HC, Ferreira T, Dias A. Sleep pathology characterization in sickle cell disease: Case-control study. Pediatr Pulmonol. 2015;50(4):396\u2013401. https:\/\/doi.org\/10.1002\/ppul.23074.","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"5626_CR44","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s11325-016-1400-6","volume":"20","author":"R Machaalani","year":"2016","unstructured":"Machaalani R, Evans CA, Waters KA. Objective adherence to positive airway pressure therapy in an Australian paediatric cohort. Sleep Breath. 2016;20(4):1327\u201336. https:\/\/doi.org\/10.1007\/s11325-016-1400-6.","journal-title":"Sleep Breath"},{"key":"5626_CR45","first-page":"115","volume":"181","author":"B Inusa","year":"2018","unstructured":"Inusa B, Stotesbury H, Koelbel M, et al. Prevention of morbidity in Sickle Cell Disease Phase II (POMS 2b paediatric cohort): improvement of pain and quality of life in children with Sickle Cell Disease with auto-adjusting Continuous Positive Airways Pressure. Br J Haematol. 2018;181:115\u20136.","journal-title":"Br J Haematol"},{"key":"5626_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1182\/blood.V130.Suppl_1.SCI-31.SCI-31","volume":"130","author":"A Slee","year":"2017","unstructured":"Slee A, Kawadler J, Koelbel M, et al. Prevention of morbidity in Sickle Cell Disease Phase II (Improvement of Cognition in children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b paediatric cohort). Blood. 2017;130:31.","journal-title":"Blood"},{"issue":"6","key":"5626_CR47","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.smrv.2011.01.003","volume":"15","author":"AM Sawyer","year":"2011","unstructured":"Sawyer AM, Gooneratne N, Marcus CL, et al. A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev. 2011;15(6):343\u201356. https:\/\/doi.org\/10.1016\/j.smrv.2011.01.003.","journal-title":"Sleep Med Rev"},{"issue":"1","key":"5626_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1586\/17474086.2.1.57","volume":"2","author":"J Knight-Perry","year":"2009","unstructured":"Knight-Perry J, Debaun MR, Strunk RC, et al. Leukotriene pathway in sickle cell disease: a potential target for directed therapy. Expert Review of Hematology. 2009;2(1):57\u201368. https:\/\/doi.org\/10.1586\/17474086.2.1.57.","journal-title":"Expert Review of Hematology"},{"issue":"4","key":"5626_CR49","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/ajh.21370","volume":"84","author":"JJ Field","year":"2009","unstructured":"Field JJ, Strunk RC, Knight-Perry JE, Blinder MA, Townsend RR, DeBaun MR. Urinary cysteinyl leukotriene E4 significantly increases during pain in children and adults with sickle cell disease. Am J Hematol. 2009;84(4):231\u20133. https:\/\/doi.org\/10.1002\/ajh.21370.","journal-title":"Am J Hematol"},{"issue":"1","key":"5626_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/2040622310383343","volume":"2","author":"P Paggiaro","year":"2011","unstructured":"Paggiaro P, Bacci E. Montelukast in asthma: a review of its efficacy and place in therapy. Ther Adv Chronic Dis. 2011;2(1):47\u201358. https:\/\/doi.org\/10.1177\/2040622310383343.","journal-title":"Ther Adv Chronic Dis"},{"issue":"3","key":"5626_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1056\/NEJM199807163390302","volume":"339","author":"JA Leff","year":"1998","unstructured":"Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L, et al. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med. 1998;339(3):147\u201352. https:\/\/doi.org\/10.1056\/NEJM199807163390302.","journal-title":"N Engl J Med"},{"issue":"3","key":"5626_CR52","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0022-3476(98)70281-1","volume":"133","author":"JP Kemp","year":"1998","unstructured":"Kemp JP, Dockhorn RJ, Shapiro GG, Nguyen HH, Reiss TF, Seidenberg BC, et al. Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma. J Pediatr. 1998;133(3):424\u20138. https:\/\/doi.org\/10.1016\/S0022-3476(98)70281-1.","journal-title":"J Pediatr"},{"issue":"1","key":"5626_CR53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/21556660.2016.1209507","volume":"5","author":"K Okubo","year":"2016","unstructured":"Okubo K, Inoue Y, Numaguchi H, Tanaka K, Saito I, Oshima N, et al. Montelukast in the treatment of perennial allergic rhinitis in paediatric Japanese patients; an open-label clinical trial. J Drug Assess. 2016;5(1):6\u201314. https:\/\/doi.org\/10.1080\/21556660.2016.1209507.","journal-title":"J Drug Assess"},{"key":"5626_CR54","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/ppul.2006","volume":"21","author":"D Skoner","year":"2001","unstructured":"Skoner D. Montelukast in 2- to 5-year-old children with asthma. Pediatr Pulmonol. 2001;21:46\u20138. https:\/\/doi.org\/10.1002\/ppul.2006.","journal-title":"Pediatr Pulmonol"},{"key":"5626_CR55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1710-1492-10-21","volume":"10","author":"D B\u00e9rub\u00e9","year":"2014","unstructured":"B\u00e9rub\u00e9 D, Djandji M, Sampalis JS, et al. Effectiveness of montelukast administered as monotherapy or in combination with inhaled corticosteroid in pediatric patients with uncontrolled asthma: a prospective cohort study. Allergy Asthma Clin Immunol. 2014;10:21.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"Supplement 1","key":"5626_CR56","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2165\/00003495-200059001-00005","volume":"59","author":"A Becker","year":"2000","unstructured":"Becker A. Clinical evidence with montelukast in the management of chronic childhood asthma. Drugs. 2000;59(Supplement 1):29\u201334. https:\/\/doi.org\/10.2165\/00003495-200059001-00005.","journal-title":"Drugs"},{"issue":"3","key":"5626_CR57","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1542\/peds.2012-0310","volume":"130","author":"AD Goldbart","year":"2012","unstructured":"Goldbart AD, Greenberg-Dotan S, Tal A. Montelukast for children with obstructive sleep apnea: a double-blind, placebo-controlled study. Pediatrics. 2012;130(3):e575\u201380. https:\/\/doi.org\/10.1542\/peds.2012-0310.","journal-title":"Pediatrics"},{"issue":"3","key":"5626_CR58","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.3.e48","volume":"108","author":"B Knorr","year":"2001","unstructured":"Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5\u2009years. Pediatrics. 2001;108(3):E48. https:\/\/doi.org\/10.1542\/peds.108.3.e48.","journal-title":"Pediatrics"},{"issue":"4","key":"5626_CR59","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1164\/rccm.200407-894OC","volume":"171","author":"H Bisgaard","year":"2005","unstructured":"Bisgaard H, Zielen S, Garcia-Garcia ML, Johnston SL, Gilles L, Menten J, et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med. 2005;171(4):315\u201322. https:\/\/doi.org\/10.1164\/rccm.200407-894OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"5626_CR60","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.sleep.2012.01.013","volume":"13","author":"AR Jackman","year":"2012","unstructured":"Jackman AR, Biggs SN, Walter LM, Embuldeniya US, Davey MJ, Nixon GM, et al. Sleep-disordered breathing in preschool children is associated with behavioral, but not cognitive, impairments. Sleep Med. 2012;13(6):621\u201331. https:\/\/doi.org\/10.1016\/j.sleep.2012.01.013.","journal-title":"Sleep Med"},{"issue":"4","key":"5626_CR61","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1365-2141.2005.05411.x","volume":"129","author":"MH Steinberg","year":"2005","unstructured":"Steinberg MH. Predicting clinical severity in sickle cell anaemia. Br J Haematol. 2005;129(4):465\u201381. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05411.x.","journal-title":"Br J Haematol"},{"issue":"1","key":"5626_CR62","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2174\/1567202612666151026105610","volume":"13","author":"P Singh","year":"2016","unstructured":"Singh P, Sharma B. Reversal in cognition impairments, cholinergic dysfunction, and cerebral oxidative stress through the modulation of ryanodine receptors (RyRs) and cysteinyl leukotriene-1 (CysLT1) receptors. Curr Neurovasc Res. 2016;13(1):10\u201321. https:\/\/doi.org\/10.2174\/1567202612666151026105610.","journal-title":"Curr Neurovasc Res"},{"issue":"1","key":"5626_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms9466","volume":"6","author":"J Marschallinger","year":"2015","unstructured":"Marschallinger J, Sch\u00e4ffner I, Klein B, Gelfert R, Rivera FJ, Illes S, et al. Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug. Nat Commun. 2015;6(1):1\u201316. https:\/\/doi.org\/10.1038\/ncomms9466.","journal-title":"Nat Commun"},{"key":"5626_CR64","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neuropharm.2015.10.005","volume":"104","author":"M Fumagalli","year":"2016","unstructured":"Fumagalli M, Lecca D, Abbracchio MP. CNS remyelination as a novel reparative approach to neurodegenerative diseases: the roles of purinergic signaling and the P2Y-like receptor GPR17. Neuropharmacology. 2016;104:82\u201393. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.10.005.","journal-title":"Neuropharmacology"},{"issue":"5","key":"5626_CR65","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.4049\/jimmunol.1100333","volume":"187","author":"L Wang","year":"2011","unstructured":"Wang L, Du C, Lv J, et al. Antiasthmatic drugs targeting the cysteinyl leukotriene receptor 1 alleviate central nervous system inflammatory cell infiltration and pathogenesis of experimental autoimmune encephalomyelitis. J Immunol. 2011;187(5):2336\u201345. https:\/\/doi.org\/10.4049\/jimmunol.1100333.","journal-title":"J Immunol"},{"key":"5626_CR66","first-page":"153","volume-title":"Handbook of Experimental Pharmacology","author":"T Tamada","year":"2016","unstructured":"Tamada T, Ichinose M. Leukotriene receptor antagonists and antiallergy drugs. In: Page C, Barnes P, editors. Handbook of Experimental Pharmacology. Cham: Springer; 2016. p. 153\u201369."},{"key":"5626_CR67","doi-asserted-by":"crossref","unstructured":"Bacharier LB, Boner A, Carlsen KCL, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. In: Allergy: European Journal of Allergy and Clinical Immunology. 2008, pp. 5\u201334.","DOI":"10.1111\/j.1398-9995.2007.01586.x"},{"issue":"10","key":"5626_CR68","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1513\/AnnalsATS.201606-432OC","volume":"13","author":"L Kheirandish-Gozal","year":"2016","unstructured":"Kheirandish-Gozal L, Bandla HPR, Gozal D. Montelukast for children with obstructive sleep apnea: results of a double-blind, randomized, placebo-controlled trial. Ann Am Thorac Soc. 2016;13(10):1736\u201341. https:\/\/doi.org\/10.1513\/AnnalsATS.201606-432OC.","journal-title":"Ann Am Thorac Soc"},{"issue":"83","key":"5626_CR69","first-page":"443","volume":"27","author":"F Shokouhi","year":"2015","unstructured":"Shokouhi F, Meymaneh Jahromi A, Majidi MR, Salehi M. Montelukast in adenoid hypertrophy: its effect on size and symptoms. Iran J Otorhinolaryngol. 2015;27(83):443\u20138.","journal-title":"Iran J Otorhinolaryngol"},{"issue":"9778","key":"5626_CR70","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","volume":"377","author":"WC Wang","year":"2011","unstructured":"Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, et al. A multicenter randomised controlled trial of hydroxyurea (hydroxycarbamide) in very young children with sickle cell anaemia. Lancet. 2011;377(9778):1663\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(11)60355-3.","journal-title":"Lancet"},{"issue":"20","key":"5626_CR71","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","volume":"332","author":"S Charache","year":"1995","unstructured":"Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med. 1995;332(20):1317\u201322. https:\/\/doi.org\/10.1056\/NEJM199505183322001.","journal-title":"N Engl J Med"},{"key":"5626_CR72","unstructured":"Paediatric Formulary Committee. BNF for Children (BNFC) 2019-2020. Pharmaceutical Press, https:\/\/vnras.com\/wp-content\/uploads\/2020\/03\/BNF-for-Children-BNFC-2019-2020-1.pdf (2019)."},{"issue":"Issue 11, Suppl","key":"5626_CR73","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1212\/WNL.0b013e3182872ded","volume":"80","author":"S Weintraub","year":"2013","unstructured":"Weintraub S, Dikmen SS, Heaton RK, Tulsky DS, Zelazo PD, Bauer PJ, et al. Cognition assessment using the NIH Toolbox. Neurology. 2013;80(Issue 11, Supplement 3):S54\u201364. https:\/\/doi.org\/10.1212\/WNL.0b013e3182872ded.","journal-title":"Neurology"},{"issue":"4","key":"5626_CR74","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10880-019-09654-y","volume":"27","author":"AM Hood","year":"2020","unstructured":"Hood AM, Reife I, King AA, White DA. Brief screening measures identify risk for psychological difficulties among children with sickle cell disease. J Clin Psychol Med Settings. 2020;27(4):651\u201361. https:\/\/doi.org\/10.1007\/s10880-019-09654-y.","journal-title":"J Clin Psychol Med Settings"},{"issue":"10","key":"5626_CR75","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/jpepsy\/jsy057","volume":"43","author":"NN Ludwig","year":"2018","unstructured":"Ludwig NN, Sil S, Khowaja MK, Cohen LL, Dampier C. Executive functioning mediates the relationship between pain coping and quality of life in youth with sickle cell disease. J Pediatr Psychol. 2018;43(10):1160\u20139. https:\/\/doi.org\/10.1093\/jpepsy\/jsy057.","journal-title":"J Pediatr Psychol"},{"issue":"8","key":"5626_CR76","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1093\/jpepsy\/jsw003","volume":"41","author":"AM Schlenz","year":"2016","unstructured":"Schlenz AM, Schatz J, Roberts CW. Examining biopsychosocial factors in relation to multiple pain features in pediatric sickle cell disease. J Pediatr Psychol. 2016;41(8):930\u201340. https:\/\/doi.org\/10.1093\/jpepsy\/jsw003.","journal-title":"J Pediatr Psychol"},{"key":"5626_CR77","doi-asserted-by":"crossref","unstructured":"Hogan AM, Hill CM, Harrison D, et al. Cerebral blood flow velocity and cognition in children before and after adenotonsillectomy. Pediatrics; 122.","DOI":"10.1542\/peds.2007-2540"},{"key":"5626_CR78","first-page":"31","volume":"181","author":"A Slee","year":"2019","unstructured":"Slee A, Stotesbury H, Kawadler J, et al. Prevention of morbidity in Sickle Cell Disease Phase 2 (POMS 2b pediatric): improvement of cognition in children with sickle cell disease with auto-adjusting continuous positive airways pressure: a single-blind, randomized, controlled phase II trial. Br J Haematol. 2019;181:31.","journal-title":"Br J Haematol"},{"issue":"8","key":"5626_CR79","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1401731","volume":"371","author":"MR DeBaun","year":"2014","unstructured":"DeBaun MR, Gordon M, McKinstry RC, et al. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med. 2014;371(8):699\u2013710. https:\/\/doi.org\/10.1056\/NEJMoa1401731.","journal-title":"N Engl J Med"},{"issue":"1","key":"5626_CR80","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1378\/chest.126.1.13","volume":"126","author":"AD Goldbart","year":"2004","unstructured":"Goldbart AD, Goldman JL, Li RC, Brittian KR, Tauman R, Gozal D. Differential expression of cysteinyl leukotriene receptors 1 and 2 in tonsils of children with obstructive sleep apnea syndrome or recurrent infection. Chest. 2004;126(1):13\u20138. https:\/\/doi.org\/10.1378\/chest.126.1.13.","journal-title":"Chest"},{"key":"5626_CR81","unstructured":"Wahlstrom D, Raiford SE, Breaux KC, et al. Contemporary intellectual assessment: theories, tests, and issues. In: Flanagan D, EM MD, editors. The Wechsler Preschool and Primary Scale of Intelligence\u2014Fourth Edition, Wechsler Intelligence Scale for Children\u2014Fifth Edition, and Wechsler Individual Achievement Test\u2014Third Edition.\u00a0New York: The Guilford Press; 2018. p. 245\u201382."},{"key":"5626_CR82","doi-asserted-by":"crossref","unstructured":"Flanagan DP, Alfonso VC. Essentials of WISC-V assessment. 1st ed.\u00a0Hoboken: Wiley; 2017.","DOI":"10.1002\/9781394258901"},{"key":"5626_CR83","doi-asserted-by":"publisher","unstructured":"Wahlstrom DA, Daniel PM, Weiss LG. Digital assessment with Q-interactive. WISC-V Clin Use Interpret. 2019;417. https:\/\/doi.org\/10.1016\/B978-0-12-815744-2.00012-4.","DOI":"10.1016\/B978-0-12-815744-2.00012-4"},{"key":"5626_CR84","doi-asserted-by":"crossref","unstructured":"Gioia GA, Isquith PK, Guy SC, et al. BRIEF-2: Behavior Rating Inventory of Executive Function. Psychological Assessment Resources, 2015.","DOI":"10.1037\/t79467-000"},{"issue":"8","key":"5626_CR85","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/pbc.24491","volume":"60","author":"JA Panepinto","year":"2013","unstructured":"Panepinto JA, Torres S, Bendo CB, McCavit TL, Dinu B, Sherman-Bien S, et al. PedsQLTM sickle cell disease module: feasibility, reliability, and validity. Pediatr Blood Cancer. 2013;60(8):1338\u201344. https:\/\/doi.org\/10.1002\/pbc.24491.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"5626_CR86","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/MPH.0000000000000177","volume":"37","author":"LM Beverung","year":"2015","unstructured":"Beverung LM, Varni JW, Panepinto JA. Clinically meaningful interpretation of pediatric health-related quality of life in sickle cell disease. J Pediatr Hematol Oncol. 2015;37(2):128\u201333. https:\/\/doi.org\/10.1097\/MPH.0000000000000177.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"8","key":"5626_CR87","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/sleep\/23.8.1d","volume":"23","author":"JA Owens","year":"2000","unstructured":"Owens JA, Spirito A, McGuinn M. The Children\u2019s Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children. Sleep-New York. 2000;23(8):1043\u201352. https:\/\/doi.org\/10.1093\/sleep\/23.8.1d.","journal-title":"Sleep-New York"},{"issue":"1","key":"5626_CR88","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1389-9457(99)00009-X","volume":"1","author":"RD Chervin","year":"2000","unstructured":"Chervin RD, Hedger K, Dillon JE, Pituch KJ. Pediatric sleep questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems. Sleep Med. 2000;1(1):21\u201332. https:\/\/doi.org\/10.1016\/S1389-9457(99)00009-X.","journal-title":"Sleep Med"},{"issue":"6","key":"5626_CR89","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540\u20135. https:\/\/doi.org\/10.1093\/sleep\/14.6.540.","journal-title":"Sleep"},{"issue":"4","key":"5626_CR90","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jaci.2006.12.662","volume":"119","author":"AH Liu","year":"2007","unstructured":"Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol. 2007;119(4):817\u201325. https:\/\/doi.org\/10.1016\/j.jaci.2006.12.662.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"5626_CR91","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/00002030-200203080-00012","volume":"16","author":"H Knobel","year":"2002","unstructured":"Knobel H, Alonso J, Casado JL, Collazos J, Gonz\u00e1lez J, Ruiz I, et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. Aids. 2002;16(4):605\u201313. https:\/\/doi.org\/10.1097\/00002030-200203080-00012.","journal-title":"Aids"},{"issue":"3","key":"5626_CR92","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1467-6427.2010.00507.x","volume":"32","author":"P Stratton","year":"2010","unstructured":"Stratton P, Bland J, Janes E, Lask J. Developing an indicator of family function and a practicable outcome measure for systemic family and couple therapy: the SCORE. J Fam Ther. 2010;32(3):232\u201358. https:\/\/doi.org\/10.1111\/j.1467-6427.2010.00507.x.","journal-title":"J Fam Ther"},{"key":"5626_CR93","doi-asserted-by":"publisher","unstructured":"Kazak AE, Alderfer M, Enlow PT, et al. COVID-19 exposure and family impact scales: factor structure and initial psychometrics. J Pediatr Psychol. Epub ahead of print 22 March 2021. DOI: https:\/\/doi.org\/10.1093\/jpepsy\/jsab026.","DOI":"10.1093\/jpepsy\/jsab026"},{"key":"5626_CR94","unstructured":"Lee K, Weiskopf N, Pathak J. A framework for data quality assessment in clinical research datasets. In: AMIA Annual Symposium Proceedings: American Medical Informatics Association; 2017. p. 1080.\u00a0Accessed 21 Mar 2019."},{"key":"5626_CR95","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing, http:\/\/www.r-project.org (2018)."},{"issue":"6","key":"5626_CR96","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1111\/jan.12755","volume":"72","author":"RD Crawford","year":"2016","unstructured":"Crawford RD, Jonassaint CR. Adults with sickle cell disease may perform cognitive tests as well as controls when processing speed is taken into account: a preliminary case\u2013control study. J Adv Nurs. 2016;72(6):1409\u201316. https:\/\/doi.org\/10.1111\/jan.12755.","journal-title":"J Adv Nurs"},{"issue":"4","key":"5626_CR97","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/bjh.13179","volume":"168","author":"V Land","year":"2015","unstructured":"Land V, Hijmans CT, Ruiter M, et al. Volume of white matter hyperintensities is an independent predictor of intelligence quotient and processing speed in children with sickle cell disease. Br J Haematol. 2015;168(4):553\u20136. https:\/\/doi.org\/10.1111\/bjh.13179.","journal-title":"Br J Haematol"},{"issue":"7","key":"5626_CR98","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.arcped.2013.04.012","volume":"20","author":"J Bockenmeyer","year":"2013","unstructured":"Bockenmeyer J, Chamboredon E, Missud F, Benkerrou M, Holvo\u00ebt L, Ithier G, et al. Development of psychological and intellectual performance in transplanted sickle cell disease patients: a prospective study from pretransplant period to 5\u2009years after HSCT. Arch Pediatr. 2013;20(7):723\u201330. https:\/\/doi.org\/10.1016\/j.arcped.2013.04.012.","journal-title":"Arch Pediatr"},{"issue":"10","key":"5626_CR99","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0165-5876(03)00182-4","volume":"67","author":"M Greenfeld","year":"2003","unstructured":"Greenfeld M, Tauman R, DeRowe A, Sivan Y. Obstructive sleep apnea syndrome due to adenotonsillar hypertrophy in infants. Int J Pediatr Otorhinolaryngol. 2003;67(10):1055\u201360. https:\/\/doi.org\/10.1016\/S0165-5876(03)00182-4.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"6","key":"5626_CR100","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.intell.2004.06.005","volume":"32","author":"H Rindermann","year":"2004","unstructured":"Rindermann H, Neubauer AC. Processing speed, intelligence, creativity, and school performance: testing of causal hypotheses using structural equation models. Intelligence. 2004;32(6):573\u201389. https:\/\/doi.org\/10.1016\/j.intell.2004.06.005.","journal-title":"Intelligence"},{"issue":"9778","key":"5626_CR101","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","volume":"377","author":"WC Wang","year":"2011","unstructured":"Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, et al. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet. 2011;377(9778):1663\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(11)60355-3.","journal-title":"Lancet"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05626-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-021-05626-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-021-05626-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T17:49:01Z","timestamp":1725904141000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-021-05626-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,10]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5626"],"URL":"https:\/\/doi.org\/10.1186\/s13063-021-05626-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2021,10,10]]},"assertion":[{"value":"7 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The South Central - Hampshire A Research Ethics Committee approved the study (19\/SC\/0569; IRAS 237674) with Medicines and Healthcare products Regulatory Agency (MHRA) approval (CTA 17328\/0228\/001-0001). Written, informed consent to participate will be obtained from all caregivers\/legal guardians of participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable as no identifying information of participants will be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"FK has received honoraria from Novartis and Bluebird Bio and has served as a consultant for Global Blood\u00a0Therapeutics. All other authors indicate that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"690"}}